Cargando…

An Unusual Presentation of Nocardiosis in an Allogeneic Transplant Recipient

Nocardiosis is a rare cause of opportunistic infection post hematopoietic stem cell transplant (HSCT) occurring in about 0.3% of patients. The risk factors include delayed immune reconstitution, prolonged neutropenia, and graft-versus-host disease. The most common site of infection is the lung, foll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Uroosa, Saqib, Amina, Mohammad, Farhan, Terjanian, Terenig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2016
Materias:	Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117707/ https://www.ncbi.nlm.nih.gov/pubmed/27904816 http://dx.doi.org/10.7759/cureus.834

Ejemplares similares

Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
por: Noviello, Maddalena, et al.
Publicado: (2023)

AN UNUSUAL CASE OF ABDOMINAL DISTENTION IN A LUNG TRANSPLANT RECIPIENT WITH COVID-19
por: LA PORTA, MARILINA, et al.
Publicado: (2021)

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning
por: Townsend, William M, et al.
Publicado: (2013)

Treatment of allosensitized patients receiving allogeneic transplantation
por: Ciurea, Stefan O., et al.
Publicado: (2021)

The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients
por: Sourisseau, Mathilde, et al.
Publicado: (2022)

An Unusual Cause of Acute Pancreatitis in a Liver Transplant Recipient
por: Nizamuddin, Imran, et al.
Publicado: (2021)

An Unusual Cause of Hepatitis With Nephrotic Syndrome in a Kidney Transplant Recipient
por: Chan, Koon Ming, et al.
Publicado: (2022)

Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
por: Gooptu, Mahasweta, et al.
Publicado: (2022)

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
por: Magenau, John M., et al.
Publicado: (2021)

Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL
por: Aldoss, Ibrahim, et al.
Publicado: (2022)

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation
por: Martin, Paul J., et al.
Publicado: (2022)

EASIX-1year and late mortality after allogeneic stem cell transplantation
por: Kordelas, Lambros, et al.
Publicado: (2023)

Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation
por: Miyata, Masahiro, et al.
Publicado: (2023)

CLINICAL OUTCOMES IN LUNG TRANSPLANT RECIPIENTS WITH SARS-COV-2
por: BOTROS, MENA, et al.
Publicado: (2021)

COURSE AND OUTCOMES OF COVID-19 INFECTIONS IN LUNG TRANSPLANT RECIPIENTS
por: NYQUIST, ALAN S, et al.
Publicado: (2022)

Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
por: Chiesa, Robert, et al.
Publicado: (2022)

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era
por: Yeh, Jason, et al.
Publicado: (2021)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
por: Arslan Davulcu, Eren, et al.
Publicado: (2023)

Hypercalcaemia preceding diagnosis of Pneumocystis jirovecii pneumonia in renal transplant recipients
por: Ling, Jonathan, et al.
Publicado: (2017)

Evaluating a Change in Surgical Antibiotic Prophylaxis in Kidney Transplant Recipients
por: Bliven, Katherine, et al.
Publicado: (2018)

Recipient Outcomes with Younger Donors Undergoing Living Donor Liver Transplantation
por: Dar, Faisal S, et al.
Publicado: (2019)

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades
por: Nishiwaki, Satoshi, et al.
Publicado: (2022)

Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant
por: Pérez-Valencia, Amanda Isabel, et al.
Publicado: (2022)

Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
por: Kanaan, Sami B., et al.
Publicado: (2023)

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
por: Murthy, Hemant S., et al.
Publicado: (2023)

An observational study of health literacy and medication adherence in adult kidney transplant recipients
por: Demian, Maryam N., et al.
Publicado: (2016)

OUTCOMES OF COVID-19 IN LUNG TRANSPLANT RECIPIENTS: A SINGLE CENTER REVIEW
por: PATEL, LOVE, et al.
Publicado: (2022)

PROLONGED COLONIZATION AND COISOLATION OF SARS-COV-2 IN UNVACCINATED RECIPIENTS OF LUNG TRANSPLANTS
por: RAZIA, DEEPIKA, et al.
Publicado: (2022)

Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant
por: Rubinstein, Jeremy D., et al.
Publicado: (2022)

Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation
por: Ren, Xiying, et al.
Publicado: (2021)

Donor bone marrow–derived macrophage engraftment into the central nervous system of patients following allogeneic transplantion
por: Loeb, Anisha M., et al.
Publicado: (2023)

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children
por: Masetti, Riccardo, et al.
Publicado: (2023)

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
por: Tamari, Roni, et al.
Publicado: (2023)

COVID-19 AND IMMUNOSUPPRESSION: A CASE OF COVID-19 IN A RENAL TRANSPLANT RECIPIENT
por: Boparai, Sukhmani, et al.
Publicado: (2020)

Variable CD34(+) recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic
por: Purtill, Duncan, et al.
Publicado: (2020)

Megadose (90)Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma
por: Chow, Victor A., et al.
Publicado: (2021)

Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission
por: Jentzsch, Madlen, et al.
Publicado: (2022)

An Unusual Presentation of Posterior Reversible Encephalopathy Syndrome Following Liver Transplantation
por: Rajakumar, Akila, et al.
Publicado: (2022)

Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
por: Weber, Daniela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9aj0jofcesaoakpj1fesptvpt6